3.6
Muscle Atrophy/Catabolism
HMB possesses an anti-catabolic effect (preserves muscle mass) which is thought to be somewhat novel when compared to Leucine supplementation, as the suppressive effects of leucine on muscle mass are maximal at 5–10mM[50] (markedly higher than fasting levels of 0.1mM[51][52] and postprandial concentrations which have been noted to be about doubled after infusions of 162-261mg/kg/h[53]) despite the attainable concentrations achievable with leucine being sufficient to promote muscle protein synthesis[54] (to a degree greater than HMB[44]) yet 0.5mM leucine appears to have poor anticatabolic effects (6.7% in this animal model that noted a 36-38% enhancement of synthesis[55]). It is possible that HMB serves a role as an anti-catabolic agent despite its lacklustre effect on muscle protein synthesis, and this is somewhat supported by leucine's anticatabolic effects being 10-20 times higher than the concentration required to promote muscle protein synthesis[50] and about 5% of leucine being converted to HMB in the body.[6]
It is plausible that HMB is the anticatabolic metabolite of leucine, whereas it alone is unable to surpass leucine in muscle protein synthesis (perhaps due to other metabolites of leucine being more potent at inducing protein synthesis) but can possibly have a role in preventing muscle loss which does not require the other metabolites of leucine nor leucine itself
At 50μM, HMB has been noted to reduce basal atrogin-1 in vitro as well as the induction of atrogin-1 by catabolic stimuli,[56] which appears to be an attainable concentrations of HMB that is associated with an increase in muscle protein synthesis.[29][18] This suggests that the anti-catabolic effects of HMB are relevant (as atrogin-1 is a protein that mediates muscle protein breakdown[57]) and although they are partly downstream of mTOR signalling[29] they are fully dependent on p38/MAPK activation (p42/44 MAPK appears to be uninvolved).[58][56]
Anticatabolic effects (in vitro) have been confirmed against glucocorticoids,[56] by the proinflammatory stimuli LPS[58][24] and TNF-α,[59][24] and Angiotension II.[59][24]
In vitro research supports the idea of HMB as being anti-catabolic, and this anticatabolic effect appears to extend to a wide variety of catabolic stressors and occurs at a concentration that is attainable following oral ingestion of HMB supplements. This occurs via p38/MAPK signalling
This is noted with 3g of HMB salts over 10 days in older adults undergoing bed rest reversing the decline in lean mass (2.05+/-0.66kg) to no significant change (0.17+/-0.19kg trending to increase);[60] which is similar to branched chain amino acids and isolated leucine.[61][62] Other studies have noted that HMB supplementation is effective in attenuating the rate of lean mass loss seen in cancer cachexia[63][64][30] and a combination of HMB with both L-Arginine and L-Glutamine has shown efficacy in AIDS patients[65] although in vitro they do not appear to be synergistically anti-catabolic.[29] Currently, the anticatabolic effects of leucine and HMB have not been directly compared.
One acute study using 3.42g HMB versus 3.42g leucine noted that while leucine outperformed HMB on muscle protein synthesis, HMB was capable of attenuating muscle protein breakdown (57%).[44]
Studies in athletes designed to assess muscle protein breakdown are limited, with one study using 3g HMB as calcium salt for 3 days in elite female judo athletes during severe caloric restriction (20kcal/kg and 1.33g/kg protein; to simulate before a contest) failing to outperform placebo.[36]
HMB supplementation has been confirmed to be anticatabolic in periods of high risk muscular wasting (cancer cachexia, AIDS, bedrest) at a feasible supplemental dosage, but there is insufficient evidence to properly assess their role in athletes. It appears to be better than leucine at this job, but requires more robust evidence to confirm